Gibson Dunn has represented Cogent Biosciences, Inc., and Mintz has advised the underwriters. Cogent Biosciences, Inc. (Nasdaq: COGT) has announced the pricing of its underwritten public…
Cogent Biosciences Announces $230 Million Convertible Senior Notes Offering

























